Temperature and Stretching Effects on Complementarity Determining Regions (CDRs) Conformation and Stability of Nimotuzumab F(ab)-Fragment
Nimotuzumab is a humanized monoclonal antibody (mAb), a potential anticancer against epidermal growth factor receptor (EGFR)overexpressed by glioma, head and neck, lung, ovarium, and colon cancers. The combination of its use with both external and internal beam radiotherapies showed improvement of t...
Main Authors: | T.S. Humani, M.A. Martoprawiro, A. Mutalib |
---|---|
Format: | Article |
Language: | English |
Published: |
Center for Development of Nuclear Informatics, National Nuclear Energy Agency (BATAN)
2015-04-01
|
Series: | Atom Indonesia |
Subjects: | |
Online Access: | http://aij.batan.go.id/index.php/aij/article/view/351 |
Similar Items
-
Fragmentation of Nimotuzumab for Preparation of 125I-F(ab’)2-Nimotuzumab as a Precursor for Preparing 125I-F(ab’)2-Nimotuzumab-NLS Radiopharmaceutical for Cancer Therapy
by: R.D. Haryuni, et al.
Published: (2014-04-01) -
Preparation of (177Lu-DOTA)n-PAMAM-[Nimotuzumab-F(ab’)2] as a Therapeutic Radioimmunoconjugate for EGFR Overexpressed Cancer Treatment
by: Titis Sekar Humani, et al.
Published: (2017-12-01) -
Biodistribution and Tumor Uptake of <sup>67</sup>Ga-Nimotuzumab in a Malignant Pleural Mesothelioma Xenograft
by: Vanessa Izquierdo-Sánchez, et al.
Published: (2018-11-01) -
Nimotuzumab y gemcitabina en el tratamiento del cáncer de páncreas y metástasis esplénica
by: Ángel Piriz Momblant, et al.
Published: (2019-07-01) -
Safety of nimotuzumab following clinical trials in head and neck epithelial tumors
by: Oneyda Clapé-Laffita, et al.
Published: (2021-05-01)